PEG is the gold standard polymer for pharmaceutical applications, however it lacks degradability.D egradation under physiologically relevantp Ha sp resent in endolysosomes,c ancerous and inflammatoryt issues is crucial for many areas. The authors presenta nionic ring-opening copolymerizationo fe thylene oxide with 3,4-epoxy-1-butene (EPB) ands ubsequent modification to introduce acid-degradable vinyl ether groups as well as methacrylate (MA) units, enabling radical cross-linking. Copolymers with different molar ratios of EPB, molecular weights (M n )u pt o 10 000 gmol À1 and narrow dispersities ( < 1.05) were prepared.B oth the P(EG-co-isoEPB)MAc opolymer and the hydrogels showedp H-dependent,r apid hydrolysis at pH 5-6 and long-term storages tabilitya tn eutral pH (pH 7.4). By designingthe degree of polymerization and content of degradable vinyl ether groups, the release time of an entrapped protein OVA-Alexa488c an be tailoredf rom af ew hours to several days (hydrolysis half-life time t 1/2 at pH 5: 13 ht o 51 h).
Introduction
Poly(ethylene glycol)( PEG) is ab iocompatible, water-soluble polymer used for cosmetics, pharmaceutics and medicala pplications. [1] Due to its low immunogenicity,a ntigenicity and toxicity,t he bioconjugation of protein drugs with PEG (known as "PEGylation") is the established gold standard employed to modify therapeuticm olecules like peptides, proteins or aptamers. [2] Furthermore, PEG is used extensively as ah ydrogel scaffold for the controlled release of biomolecules [3] or cells [4] in regenerative medicine. [5] The PEG deliveryv ehiclest akea dvantage of the versatility of the PEG chemistry that allows for a tailored design of the required hydrogel properties.A lthough mechanical [6] and biological properties [7] as well as hydrogel porosity [8] can be optimized independently,a djusting the degradability withouta lteringt he aforementioned properties remainsachallenge. In general, PEG hydrogels lack degradability underp hysiological conditions withinr elevant time spans.H ydrogels derived from traditional diacrylated PEG (PEGDA) are hydrolyzed slowly and unspecifically in vivo, which renders them unsuitable for long-terms toragea sw ell as for implantable applications. [9] Therefore, the use of nondegradable PEG molecules larger than 30 kDa for medicalapplicationsislimited becauset hese cannotb ee xcreted by the kidney due to the kidney-threshold andm ay accumulate in the tissue. [10] However,t he use of hydrogels composed of high molecular weight PEG chains would result in larger average pore size and greater swelling ability of the gel, whichi st hought to be favorable for the releaseo fl argert herapeuticm olecules depending solely on diffusion [11] like antibodies. This approachc an be advantageousw hen considering ac onstant diffusive release. Alternatively,a cid-triggered controlled release combined with advanced storages tability is typical for hydrogels from shorter, degradable PEG chains eliminating unspecific drug released epending solely on diffusion. Thism ay open an ew range of applications for the use of PEG hydrogels for in vivo applications, for example, degradable injectable hydrogels, micro-o rn anosized deliveryv ehicles, wound-healing hydrogelp atches, and directedd rug deliveryf or tumor treatment.
In this context,c onsiderable efforts have been devoted to synthesize intrinsicallyc leavable PEGs that respond to environ-mental stimuli. [1, 12] Polymer cleavability in acidic environment as found intracellularly inside the endolysosome, [13] in inflamed tissue, [11a, 14] tumor tissue, [15] or vaginal tissue [16] can be achieved by inserting acid-labile moieties. [17] Various innovative approaches for introduction of acid-degradable functional groups into ap olyether backbonew ere reported. These strategies include step-growth polymerization, oxidation, or copolymerization with epichlorohydrin or lactide, or by introducing acetals, [18] ketals, [19] hydrazones, [20] cis-acetonitic acids, [21] maleamic acid derivatives, [22] imines, [23] b-thiopropionates, [24] or esters. [25] However,t hese strategies generate either polydisperse materials or polymers with ill-definede nd-groups. [26] The availability of nearly monodisperse, high molecularw eightP EGs with acid-labile vinyl ether degradation sites has the potential to open up av ast range of applications using PEG hydrogels in vivo. Here, we present well-definedP EG buildingb locks with cross-linkable end groups that degrade at physiologically relevant pH in practicablet ime scales, while preserving long-term storages tability. Furthermore, we demonstrate that the size of the nontoxic degradation products can be tailoredb yc ustomizing the number of degradable vinyl ether units per polymer chain.
Results and Discussion

Synthesis
Recently,w ee stablished the synthesis of multi allyl ether-functional PEG by anionic ring-opening copolymerization of ethylene oxide (EO) and 3,4-epoxy-1-butene (EPB). [27] Copolymerization of EPB and EO was performedi naDMSO/THF mixture at room temperatureb yu sing sodium hydride as ab ase (see Scheme1).
We use triethylene glycol as ab ifunctional initiator resulting in well-defined P(EG-co-EPB) copolymers ( = 1.03-1.05) with adjustable EPB content( 5-10 mol %) and molecular weight (5000-10000 gmol À1 ,s ee Table 1 ). Isomerization of the allyl moietiesw ith Wilkinson'sc atalyst RhCl(PPh 3 ) 3 results in vinyl ethers( isoEPB)t hat exhibit fast hydrolysis in slightly acidic conditions, while being long-term stable under neutral conditions. [27] In the final step, methacrylate units are attached to the degradable polymers using an enzyme-catalyzed, mild esterification reaction. The latter simple modification enables radicalc rosslinking of the PEG copolymerb uilding block to degradableh ydrogels that are suitable for drug delivery and controlledr elease.
Characterization
All synthesized copolymers werec haracterized by 1 HNMR, size exclusion chromatography (SEC) and mass spectrometry (MALDI-ToF). Exemplarily,t he data of P(EG 168 -co-EPB 13 )a nd its derivatives are discussed in the main text.E xtensive analytical data of the other polymers can be found in the Supporting Information.M olecular weights were calculated from 1 HNMR spectra by comparing the signals of the ethylene oxide polymer backbone with the signalo ft he hydroxyl units. The percentage of EPB incorporation was calculated by comparing the integralso ft he allyl NMR signals at 5.84 ppm and 5.74 ppm (EPB) or the vinyl NMR signal at 4.78 ppm (isoEPB) with the signal of the two hydroxyl end-groups at 4.6 ppm. Isomerization with Wilkinson's catalystr esulted in the disappearance of the EPB signals between 6.0 and 5.2 ppm and the appearance of the vinyl ether signals at 4.8-4.5 ppm (see Figure S19 , Supporting Information). SEC underestimates the actual molecular weights because of the different hydrodynamic volume of the copolymer that is compared to the PEG standard used for SEC calibration. All SEC traces showed monomodalm olecular weight distributions, and molecular weights did not change significantly upon post-polymerization functionalization. At ypical 1 HNMR spectrum of P(EG-co-isoEPB)MAi sg iven in Figure 1a .S EC traces of P(EG 168 -co-EPB 13 )c opolymera nd its derivatives are presentedi nF igure 1b.M ALDI-ToF was performed to confirmt hat all polymers were initiated from triethylene glycol andt oc onfirmc opolymeriza-Scheme1.Copolymerization of EO and EPB as well as post-polymerization isomerization and methacrylate derivatization. To comprehend the monomer sequence distribution during anionic ring-opening copolymerization, on-line 1 HNMR measurements-a technique that has been provene xtremely useful to monitor polymerization reactions in situ [28] -has been employed during copolymerization of EPB and EO. The reactivity ratios were determined by fitting the in situ data to the ideal copolymerization model to be r EPB = 0.35 and r EO = 2.8 ( Figure S33 , Supporting Information). [29] The results were confirmed by classical aliquot takinga td etermined points in time from the bulk polymerization reaction. Based on these reactivity ratios the averagem icrostructure was depicted for ac opolymer started by ab ifunctionalinitiator with the same compositiona sP (EG 168 -co-EPB 13 ), see Figure1c. Individual copolymer chains obtained by aM onte Carlo simulation carriedo ut for the compositiono fP (EG 168 -co-EPB 13 ), based on the determined reactivity ratios and living polymerization behavior,a re displayed in Figure 1d .I ncorporation of EPB moieties results in ag radientm icrostructure with higherr atio of EPB at the terminio ft he polymer chains and lower EPB content near the bifunctionalinitiator.
To investigate the biocompatibility of the polymer to cells, in vitro cell studies with MG-63 and primaryH UVEC cells were conducted. As olution of 50-500 mgmL À1 P(EG 92 -co-isoEPB 6 ) was added to the cell culture and vitality staining with Calcein-AM was performeda fter 24 h, 72 ha nd 7d ays. For MG-63 cells, no difference compared to the untreated control cells was detected upon incubation of 500 mgmL À1 P(EG 92 -co-isoEPB 6 )a fter 7days of culture. For primary HUVEC cells, only for the highest concentration of 500 mgmL À1 tested, P(EG 92 -co-isoEPB 6 )s howedd iminished cell survival after 72 ho fc ell culture. For 100 mgmL À1 ,n od ifference compared to the untreated controlc ells was observed.
Macromonomer degradation
The vinyl ether units within the P(EG-co-isoEPB)MA polymer backbonea re susceptible to hydrolysisu pon acidification (see Figure 2a ,b ottom). The macromonomersb reak down completely upon incubation with dilute HCl overnight. Subsequently,b ase wasa dded to adjust the pH above 3, and degradation fragments were analyzed by SEC (representative elution trace is displayed in Figure 2a ,t op). Half-life degradation times for hydrolysis were determined with 1 HNMR, as described previously [27] (Table 1 ). The EPB content was tailoredt ogive degradation productso f6 70-900gmol À1 ,w hicha llow for renal excretion. The degradation behaviorc an be predicted by the MonteC arlo simulations hown in Figure S26 ( Supporting Information). In the simulated degradationo fP (EG 168 -co-EPB 13 )t he PEG-fragments show av ery similar size distribution to that obtained experimentally.
Hydrogel synthesis, degradationand proteinrelease
To obtain ah ydrogel, 10 wt %P (EG-co-isoEPB)MAs olutions were mixed with 2-hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone (photoinitiator in ethanolics olution( 1:10)) and cross-linked for1 5min, by using a3 65 nm UV lamp and a9 6 well plate at pH 7.4. Employing this composition results in transparent hydrogels with defined edges that hold the shape of the mold well. Furthermore, the good mechanical stability of the hydrogels allows for easy handling with tweezers.T o help monitoring the hydrogel degradation during macroscopic degradation studies with the unaided eye, the gel was loaded with the dye labelled model protein OVA-Alexa488. This results in transparent yellowish gels (Figure 2b ). Hydrogel disks from copolymer P(EG 168 -co-isoEPB 13 )MA werei ncubated in ap hosphate-citrate buffer at pH 4, 5o r6o rp hosphate buffer at pH 7.4 as ac ontrol (compare Figure 2b) . The plastic Petri dishes containing the buffer solution and hydrogel were incubated at room temperature. The control hydrogel at pH 7.4 remained unchanged for periodse xceeding 5days, whereas the hydrogel incubated at pH 4d isintegrated within 5hours, the hydrogel at pH 5w ithin 18 hours and the hydrogel at pH 6 within 72 hours.T hese results demonstrate that 10 wt %h ydrogels comprising the synthesized P(EG 168 -co-isoEPB 13 )MA macromonomer degraded quickly under physiologicalc onditions of pH 5-6, as found in the endolysosome or inflamed tissue while being stable when stored in neutrals olutions for several months (data not shown). It should be noted that the proton diffusion occurs on much shortert ime scales than those of the observed degradation and OVA-Alexa 488 releaseoft he hydrogels. This provest hat the polymer hydrolysis is location-independent and takes place in the entireg el simultaneously (see Figure S38 , Supporting Information). This shows that hydrogels can be perfused with small molecules for possible application as ab ioreactor when enzymaticallya ctive proteins are encapsulatedi nt he hydrogel. Furthermore, the protein release from a1 0wt% P(EG-co-isoEPB)MA hydrogel was investigated by using absorbance measurements at 496 nm in ad isposable PMMA cuvette. To ensure that the change in absorbance measured arose exclusivelyf rom the released protein and not from the protein encapsulated in the hydrogel, ac uvette with an incubation chamber for the hydrogel with spatial separation from the absorbance beam path was designed (see Figure 2c , left and Figure S34 , Supporting Information). Thea cidified buffer solution was stirred constantly with am agnetic stir bar, while the absorbance was measured every 5minutes until the absorbance signal remained constant. Incubation of the hydrogel in more acidic buffersolutionresulted in faster degradation (see Figure2c), whereas incubation at neutral pH did not lead to significant release over the same period of time. We normalized the absorbance values of hydrogels prepared from differ- ent macromonomers and degraded at different pH, since the absorbance of OVA-Alexa488 differs with pH. Three trends can be observed:1)The lower the pH, the faster hydrogel degradation and consequently protein release take place. 2) In addition, with increasing content of degradable vinyl ether units in the macromonomers, the degradation rate increases. 3) The highest degradationr ate was observed for the hydrogel composed of the largestm acromonomer with high EPB molarc ontent. Alternatively,t he lowest degradation rates are observed for the smallest macromonomer with low EPB content under otherwise similarconditions.
These findings can be rationalized by considering network density,w hich determines protein diffusion. As shown in Figure 2c,t he protein release rate from the networks increases once af ew isoEPB units are cleaved. In case of slow release of OVA-Alexa488, the absence of an initial burst releasei so bserved. When the protein-loadedh ydrogels are incubated first at neutralp H( pH 7.4), the protein release reaches ap lateau once the surface-adsorbed protein is released (see Figures S28 and S35, Supporting Information). Subsequentt ransfer of the hydrogel into as lightly more acidic solution (pH 6) results in continued protein release. Similar behavior is visible for the network obtained from the smallest copolymer P(EG 112 -co-isoEPB 5 )i ncubated at pH 5, for which the densely cross-linked hydrogel in the beginning only allowss urface-adsorbed OVA-Alexa488t ob ew ashed out. After ac ertain periodo ft ime, a critical amounto fisoEPB units is cleaved to open up larger pores for OVA-Alexa488 to diffuse out of the hydrogel. This trend can be observed both at pH 4a nd at pH 5.
The hydrolysis half-life time (t 1/2 )a tp H4 ranges from 2.3 to 4.5 hours and at pH 5f rom 13 to 51 hours, depending on the copolymer employed (see Ta ble 1). The P(EG 168 -co-isoEPB 13 )MA macromonomer [t 1/2 (pH 5) = 13 h] is superior to previously published PEG-acetal macromonomers that required much longer time for degradation at physiological relevant pH values [t 1/2 (pH 5) = 48 h]. [30] Likewise, it outperforms ketal-PEG macromonomers that degrade very quickly at acidic pH, but are not stable in neutral solutions, impeding storage for prolonged periods. [31] The degradation behavior of ahydrogel consisting of the co-polymerP (EG 168 -co-isoEPB 13 )i si nvestigated by straightforward incubation at different pH values as well as by on-line absorbance releasek inetics of entrapped OVA-Alexa488 (Figure 2b,c) . Timescales of the hydrogel degradation behavior obtainedb y the two differentm ethods are in good correlation, confirming these results.
In general,s ignificant protein release( OVA-Alexa488, 45 kDa) from an ondegradable hydrogel of 10 wt %P EG with molecular weights of approximately 6000 Da does not occur. [32] This together with the fact that we cannot see as ignificant protein releaseo ft he hydrogel based on the largest macromonomer at pH 7.4 (compare Figure S27 ), butaremarkable releasea t pH 4, 5a nd 6e vidences that the protein release from the hydrogels dependss olely on acid stimuli and is not due to diffusion.
Conclusions
In summary,w eh ave developed an ew acid-degradable PEG hydrogel for pH-controlled degradation and protein release. Anionic ring-opening copolymerization of ethylene oxide and 3,4-epoxy-1-butene (EPB) allowsf or the precise adjustment of molecular weights and determinest he content of degradable units within the polyether chainsi nt he network. The reaction yields well-definedP (EG-co-EPB) copolymers with molecular weights from 5000 to 10 000 gmol À1 (dispersities below 1.05) and high or low EPB content.M ild enzymatic conditions have been employed to obtain cross-linkable and degradable P(EG-co-isoEPB) methacrylatem acromonomers. The highly water-soluble macromonomers readily degrade at physiologically relevant pH (pH 5-6) present in endolysosomes, inflammatorya nd cancerous tissue, while being stable for several weeks in solution at neutralp H( pH 7.4). Hydrogels prepared from the new macromonomers degrade macroscopically within 5hours (pH 4), 18 hours (pH 5) or 72 hours (pH 6). The releaseo fa ne ncapsulated protein OVA-Alexa488 was monitored using ac ustom-designed releases etup for on-line absorbance measurements andl asted between 13 hours for the hydrogel from the largest macromonomer with high EPB content to 51 hours for the hydrogel from the smallest macromonomer with low EPB content at pH 5. As expected, the hydrogels releaset he protein faster in more acidic buffer (pH 4, 2.3-4.5 hours) compared to lessa cidic conditions (pH 5, 13-51 hours). In neutralp H, no significant protein release can be detected.
The presented synthetic strategy paves the way for an ew type of PEG hydrogel that combinest he outstandingp roperties of PEG as ah ydrogel constituent (e.g.,b iocompatibility, water-solubility and low immunogenicity) with degradationa t physiologically relevant pH. To the best of our knowledge, long-term storages tability at pH 7.4 in combinationw ith degradationa tp H6 reflects au niquelyp recise pH sensitivity.I n that respect, the concept also offers great potential for degradable PEG hydrogel nanocarriers. [30] Experimental Section
Polymerization of P(EG-co-EPB)
The procedure is exemplarily described for the synthesis of copolymer P(EG 168 -co-EPB 13 ). It was carried out similarly for all P(EG-co-EPB) copolymers presented in this paper.S odium hydride (7 mg, 0.31 mmol) was transferred into ad ry Schlenk flask and as olution of triethylene glycol (117 mg, 0.778 mmol) in benzene (6 mL) was added. The solution was stirred under slightly reduced pressure at 60 8Cf or 30 min keeping the stopcock closed. Moisture was removed by azeotropic distillation of benzene and subsequent drying at 60 8Ci nh igh vacuum for 16 h. After cooling to RT,d ry THF (4 mL) was cryo-transferred into the Schlenk flask to dissolve the initiator.E PB (1.44 mL, 17.9 mmol, stirred over CaH 2 for 30 min and freshly distilled prior to use) and dry DMSO (7 mL) were injected into the Schlenk flask by using as yringe at À80 8C. Ethylene oxide (5 mL, 0.11mol) was cryo-transferred with ag raduated ampule, and the polymerization was proceeded at RT for 7days and was subsequently quenched with methanol (2 mL). After dialy-
